Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a newly discovered and rare cancer possibly associated with textured breast implants. This literature review investigates its epidemiology, pathophysiology, and risk factors. PubMed, LILACS, and SciELO databases were searched fro...

Full description

Bibliographic Details
Main Authors: Daniel Sundfeld Spiga Real, Beatriz Sant'ana Resendes
Format: Article
Language:English
Published: Sociedade Brasileira de Cirurgia Plástica 2019-12-01
Series:Revista Brasileira de Cirurgia Plástica
Subjects:
Online Access:http://www.rbcp.org.br/export-pdf/2670/en_v34n4a14.pdf
_version_ 1827611493709905920
author Daniel Sundfeld Spiga Real
Beatriz Sant'ana Resendes
author_facet Daniel Sundfeld Spiga Real
Beatriz Sant'ana Resendes
author_sort Daniel Sundfeld Spiga Real
collection DOAJ
description Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a newly discovered and rare cancer possibly associated with textured breast implants. This literature review investigates its epidemiology, pathophysiology, and risk factors. PubMed, LILACS, and SciELO databases were searched from December 2018 to February 2019, and 10 articles published between 2016 and 2018 were selected. The incidence of BIA-ALCL ranged from 2.8:100,000 to 1:3 million breast implants. The obtained data corroborate the hypothesis that there is no direct cause and effect relationship between breast implants, especially textured implants, and BIA-ALCL, and these implants can be considered risk factors but not causative factors. The most accepted hypothesis on disease pathophysiology is that breast implants with larger surface areas may promote bacterial adhesion and biofilm formation, leading to severe chronic inflammation, triggering the malignant transformation of T cells. This review provides knowledge on BIA-ALCL and helps develop and implement public policies for disease prevention and timely diagnosis. The data highlight that long-term follow up is necessary and that surgeons should advise patients of the potential risk of developing BIA-ALCL before performing the implant surgery.
first_indexed 2024-03-09T08:07:11Z
format Article
id doaj.art-11d858cece4e46569d76d4e3458decb7
institution Directory Open Access Journal
issn 1983-5175
2177-1235
language English
last_indexed 2024-03-09T08:07:11Z
publishDate 2019-12-01
publisher Sociedade Brasileira de Cirurgia Plástica
record_format Article
series Revista Brasileira de Cirurgia Plástica
spelling doaj.art-11d858cece4e46569d76d4e3458decb72023-12-02T23:43:50ZengSociedade Brasileira de Cirurgia PlásticaRevista Brasileira de Cirurgia Plástica1983-51752177-12352019-12-01340453153810.5935/2177-1235.2019RBCP0234Breast implant-associated anaplastic large-cell lymphoma: a systematic literature reviewDaniel Sundfeld Spiga Real0Beatriz Sant'ana Resendes1Universidade Federal de São Carlos, São Carlos, SP, BrazilUniversidade Federal de São Carlos, São Carlos, SP, BrazilBreast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a newly discovered and rare cancer possibly associated with textured breast implants. This literature review investigates its epidemiology, pathophysiology, and risk factors. PubMed, LILACS, and SciELO databases were searched from December 2018 to February 2019, and 10 articles published between 2016 and 2018 were selected. The incidence of BIA-ALCL ranged from 2.8:100,000 to 1:3 million breast implants. The obtained data corroborate the hypothesis that there is no direct cause and effect relationship between breast implants, especially textured implants, and BIA-ALCL, and these implants can be considered risk factors but not causative factors. The most accepted hypothesis on disease pathophysiology is that breast implants with larger surface areas may promote bacterial adhesion and biofilm formation, leading to severe chronic inflammation, triggering the malignant transformation of T cells. This review provides knowledge on BIA-ALCL and helps develop and implement public policies for disease prevention and timely diagnosis. The data highlight that long-term follow up is necessary and that surgeons should advise patients of the potential risk of developing BIA-ALCL before performing the implant surgery.http://www.rbcp.org.br/export-pdf/2670/en_v34n4a14.pdfbreast implantanaplastic large-cell lymphomat-cell lymphomanon-hodgkin's lymphomabreast cancer
spellingShingle Daniel Sundfeld Spiga Real
Beatriz Sant'ana Resendes
Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review
Revista Brasileira de Cirurgia Plástica
breast implant
anaplastic large-cell lymphoma
t-cell lymphoma
non-hodgkin's lymphoma
breast cancer
title Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review
title_full Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review
title_fullStr Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review
title_full_unstemmed Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review
title_short Breast implant-associated anaplastic large-cell lymphoma: a systematic literature review
title_sort breast implant associated anaplastic large cell lymphoma a systematic literature review
topic breast implant
anaplastic large-cell lymphoma
t-cell lymphoma
non-hodgkin's lymphoma
breast cancer
url http://www.rbcp.org.br/export-pdf/2670/en_v34n4a14.pdf
work_keys_str_mv AT danielsundfeldspigareal breastimplantassociatedanaplasticlargecelllymphomaasystematicliteraturereview
AT beatrizsantanaresendes breastimplantassociatedanaplasticlargecelllymphomaasystematicliteraturereview